WEBVTT 00:00:00.080 --> 00:00:05.173 The UK is home to over 130,000 social enterprises, each trying 00:00:05.173 --> 00:00:07.760 to have an impact on our nation. 00:00:11.000 --> 00:00:15.294 The BCG UK Social Enterprise Award seeks to elevate the most 00:00:15.294 --> 00:00:19.160 innovative and exciting social enterprises in the UK. 00:00:20.000 --> 00:00:23.845 It has been a privilege to meet some of the UK's most impressive 00:00:23.845 --> 00:00:27.515 social entrepreneurs and hear about the impact they're driving 00:00:27.515 --> 00:00:30.720 in the fields of health, education and social mobility. 00:00:34.040 --> 00:00:37.800 Nesta wanted to support the Social Enterprise Award because 00:00:37.800 --> 00:00:41.376 we are a charitable foundation with the sole objective to 00:00:41.376 --> 00:00:44.705 support innovation that can have a positive social or 00:00:44.705 --> 00:00:46.000 environmental impact. 00:00:46.120 --> 00:00:49.156 And we think this prize, through the support that BCG can offer, 00:00:49.156 --> 00:00:51.865 can genuinely transform the trajectories of the companies 00:00:51.865 --> 00:00:53.079 that they're working with. 00:00:53.760 --> 00:00:57.388 From our perspective at the Cambridge Centre for Social 00:00:57.388 --> 00:01:01.536 Innovation, we need more spaces and discussions and awards such 00:01:01.536 --> 00:01:05.683 as this to raise the profile of scalable social enterprises and 00:01:05.683 --> 00:01:09.506 to support and nurture more social innovation, more social 00:01:09.506 --> 00:01:09.960 impact. 00:01:14.760 --> 00:01:19.355 And so I'm very pleased to announce that Tessa Jowell Brain 00:01:19.355 --> 00:01:19.920 Cancer Mission [is our winner]. 00:01:21.960 --> 00:01:25.242 For us, this award will mean that we can think really hard 00:01:25.242 --> 00:01:28.316 about how to go deeper for patients with a brain tumour in 00:01:28.316 --> 00:01:31.130 terms of providing them equitable access to research, 00:01:31.130 --> 00:01:32.120 treatment and care. 00:01:32.440 --> 00:01:35.803 And also to start thinking about rolling out our model to cancer 00:01:35.803 --> 00:01:38.080 patients with other hard to treat cancers.